Lista de obras - Dhifaf Sarhan - Dominio Público Uruguay

A novel inhibitor of proteasome deubiquitinating activity renders tumor cells sensitive to TRAIL-mediated apoptosis by natural killer cells and T cells.

artículo científico publicado en 2013

Activated monocytes augment TRAIL-mediated cytotoxicity by human NK cells through release of IFN-γ

scientific article published on 26 October 2012

Adaptive NK Cells Resist Regulatory T-cell Suppression Driven by IL37.

artículo científico publicado en 2018

Adaptive NK Cells with Low TIGIT Expression Are Inherently Resistant to Myeloid-Derived Suppressor Cells

artículo científico publicado en 2016

Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β.

artículo científico publicado en 2015

Doxorubicin sensitizes human tumor cells to NK cell- and T-cell-mediated killing by augmented TRAIL receptor signaling

artículo científico publicado en 2013

Enhanced stimulation of human tumor-specific T cells by dendritic cells matured in the presence of interferon-γ and multiple toll-like receptor agonists.

artículo científico

GSK 3 inhibition drives maturation of NK cells and enhances their antitumor activity

artículo científico publicado en 2017

HER2/HER3 signaling regulates NK cell-mediated cytotoxicity via MHC class I chain-related molecule A and B expression in human breast cancer cell lines

artículo científico publicado en 2012

Independent control of natural killer cell responsiveness and homeostasis at steady-state by CD11c+ dendritic cells.

artículo científico publicado en 2016

Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity

artículo científico publicado en 2014

Inhibiton of tumor-derived prostaglandin-e2 prevents the induction of human myeloid-derived suppressor cells (MDSCs) and rescues anti-tumor immunity

Mesenchymal stromal cells shape the MDS microenvironment by inducing suppressive monocytes that dampen NK cell function

scientific article published on 12 March 2020

Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity